Introgen Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics

INGN 6.690

+0.1%

Dec 24 12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (758)	12/19/2007 3:06:46 PM
From: Jibacoa	Read Replies (1) of 802

INGN Is up above the resistance at $4.25 & volume is close to 2x its ADV. Message 24148414 It seems that AF will have to come out soon with another tirade against INGN if he wants to save the shorts before any more news come out about the MAA for Advexin, which according to Gendux, has now been accepted for technical review by the EMEA for the treatment of LFS cancers. According to Gendux, all administrative issues have been addressed and the formal technical evaluation of the MAA will be conducted under the EMEA’s "Exceptional Circumstances Approval Rules." It seems that the stock could have a spike at any time.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next